Drugs / Selenium ACE
last change Oct 2014 re-read 2 minutes ago

Selenium ACE

Developed for
nephrolithiasis

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT01675362 Comparator Aug 2012 → Aug 2014 nephrolithiasis Mansoura University Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Selenium ACE “They will be receive vitamins A, C, E and selenium (Selenium ACE) Dosage: Two tablets before ESWL Then 2 tablets every 8 hours after ESWL for one week” NCT01675362